ITRM - Iterum Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 597.51M
Enterprise Value 367.3M
Trailing P/E N/A
Forward P/E 1-2.19
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)183.98
Price/Book (mrq)3.93
Enterprise Value/Revenue 3126.98
Enterprise Value/EBITDA 6-0.70

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-27.89%
S&P500 52-Week Change 32.16%
52 Week High 311.22
52 Week Low 34.70
50-Day Moving Average 36.64
200-Day Moving Average 36.84

Share Statistics

Avg Vol (3 month) 38.51k
Avg Vol (10 day) 312.75k
Shares Outstanding 514.37M
Float 4.54M
% Held by Insiders 18.97%
% Held by Institutions 175.71%
Shares Short (Jul 31, 2019) 445.31k
Short Ratio (Jul 31, 2019) 47.88
Short % of Float (Jul 31, 2019) 40.83%
Short % of Shares Outstanding (Jul 31, 2019) 40.32%
Shares Short (prior month Jun 28, 2019) 432.45k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-18,259.24%

Management Effectiveness

Return on Assets (ttm)-55.81%
Return on Equity (ttm)-136.10%

Income Statement

Revenue (ttm)530k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)869k
EBITDA -96.63M
Net Income Avi to Common (ttm)-97.38M
Diluted EPS (ttm)-7.05
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.02M
Total Cash Per Share (mrq)3.61
Total Debt (mrq)21.81M
Total Debt/Equity (mrq)88.75
Current Ratio (mrq)2.10
Book Value Per Share (mrq)1.71

Cash Flow Statement

Operating Cash Flow (ttm)-84.78M
Levered Free Cash Flow (ttm)-48.86M